Gross profit decreased 24.6%
Gross profit changed -24.6% from the comparable as-filed period.
$244.0M→$184.0M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CBT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 6.6%
Inventory changed +6.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$531.0M→$566.0M4 prior comparisons
Revenue increased 6.4%
Revenue changed +6.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$923.0M→$982.0M3 prior comparisons
Research & development decreased 13.3%
Research & development changed -13.3% from the comparable as-filed period.
$15.0M→$13.0M3 prior comparisons
Selling, general & administrative increased 17.7%
Selling, general & administrative changed +17.7% from the comparable as-filed period.
$62.0M→$73.0M3 prior comparisons
Inventory / revenue moved 11 bp higher
Inventory / revenue changed +11 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
57.53%→57.64%3 prior comparisons
Cash & equivalents increased 4.6%
Cash & equivalents changed +4.6% from the comparable as-filed period.
$239.0M→$250.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.